TRANSFREEMATION IVS: Financial statements 2020
CVR: 37192341
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
TRANSFREEMATION IVS (CVR 37192341) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 9,446 and a net result of DKK -23,681 compared with DKK 6,459 the year before. That is a decrease of 88.1% compared with the year before. The profit margin was -250.7%. Equity in the 2020 report amounted to DKK -10,419.
- Revenue
- DKK 9,446
- Gross Profit
- DKK -23,681
- Profit/Loss
- DKK -23,681
- Equity
- DKK -10,419
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 9K | -24K | -24K | -10K | - |
| 2019 | 79K | 35K | 6K | 13K | - |
| 2018 | 23K | 15K | -201 | 7K | - |
| 2017 | 55K | 28K | 10K | 7K | - |
Official annual report
How creditworthy is TRANSFREEMATION IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
TRANSFREEMATION IVS has published its annual report for 2019. Revenue came to DKK 79,218, and the net result was DKK 6,459.
About TRANSFREEMATION IVS
TRANSFREEMATION IVS was a Danish company of the type Iværksætterselskab based in Vodskov, founded in 2015. The company has been dissolved on 1 April 2022. The company was registered under the industry Anden undervisning i.a.n.. In 2020, the company reported revenue of DKK 9,446 and a net result of DKK -23,681 compared with DKK 6,459 the year before. Equity in the 2020 report amounted to DKK -10,419.